Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XBI vs. GNOM: which is better?

Bottom line

XBI vs GNOM: the short answer

XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and GNOM (Global X Genomics & Biotechnology ETF) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.

But XBI is far broader, holding 161 positions to 51 for GNOM, so beyond the top names it adds exposure GNOM doesn't have.

XBI is cheaper at 0.35% vs 0.5% — a difference of $15 a year per $10,000 invested.

Over five years, XBI returned −2.7% a year vs −13.3% for GNOM.

Updated Nov 19, 2026

XBI vs GNOM side by side

XBIGNOM
TypeETFETF
Fund familySPDR (State Street)Global X
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.5%
Annual cost per $10k$35$50
10-yr cost on $10k (prospectus)$443$628
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+35.8%+19.0%
5-yr return (annualized)−2.7%−13.3%
10-yr return (annualized)+5.8%—
Best quarter+44.4%+38.8%
Worst quarter−26.2%−24.2%
Net assets (fund)$10.7B$55.8M
Number of holdings16151
Portfolio turnover71%34%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXBIGNOMDifference
2025+35.8%+19.0%+16.8%
2024+1.1%−16.2%+17.3%
2023+7.5%−8.6%+16.1%
2022−25.8%−36.1%+10.3%
2021−20.5%−16.0%−4.5%
2020+48.2%+51.6%−3.4%

Source: Fund prospectus bar charts

Holdings overlap

5 of XBI's top 25 holdings also appear in GNOM's top 25.

Shared top holdings
HoldingXBIGNOM
Moderna Inc1.41%3.28%
Twist Bioscience Corp1.41%3.97%
Praxis Precision Medicines Inc1.29%4.01%
Natera Inc1.16%4.15%
Ultragenyx Pharmaceutical Inc1.14%2.25%

Source: SEC Form N-PORT

XBI top 10

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Moderna Inc — 1.41%
  4. Twist Bioscience Corp — 1.41%
  5. Oruka Therapeutics Inc — 1.38%
  6. Kymera Therapeutics Inc — 1.36%
  7. Viking Therapeutics Inc — 1.30%
  8. Praxis Precision Medicines Inc — 1.29%
  9. Erasca Inc — 1.27%
  10. Revolution Medicines Inc — 1.20%

GNOM top 10

  1. Guardant Health, Inc. — 5.59%
  2. Illumina, Inc. — 4.82%
  3. Natera, Inc. — 4.15%
  4. Biomarin Pharmaceutical Inc. — 4.09%
  5. Arrowhead Pharmaceuticals, Inc. — 4.07%
  6. Legend Biotech Corp — 4.05%
  7. Praxis Precision Medicines Inc — 4.01%
  8. Twist Bioscience Corp — 3.97%
  9. Vertex Pharmaceuticals Incorporated — 3.95%
  10. CRISPR Therapeutics AG — 3.85%

FAQ

What is the difference between XBI and GNOM?
XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and GNOM (Global X Genomics & Biotechnology ETF) are quite different portfolios: only about 18% of their top holdings (by weight) are shared. But XBI is far broader, holding 161 positions to 51 for GNOM, so beyond the top names it adds exposure GNOM doesn't have.
Which is cheaper, XBI or GNOM?
XBI has the lower expense ratio (0.35%).
Should I own both XBI and GNOM?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.